Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 126

1.

Exclusion of pregnancy in dialysis patients: diagnostic performance of human chorionic gonadotropin.

Haninger-Vacariu N, Herkner H, Lorenz M, Säemann M, Vychytil A, Jansen M, Marculescu R, Kramar R, Sunder-Plassmann G, Schmidt A.

BMC Nephrol. 2020 Feb 28;21(1):70. doi: 10.1186/s12882-020-01729-5.

2.

Employment Status and Associations with Workability, Quality of Life and Mental Health after Kidney Transplantation in Austria.

Jordakieva G, Grabovac I, Steiner M, Winnicki W, Zitta S, Stefanac S, Brooks M, Sunder-Plaßmann G, Rosenkranz AR, Godnic-Cvar J.

Int J Environ Res Public Health. 2020 Feb 15;17(4). pii: E1254. doi: 10.3390/ijerph17041254.

3.

Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report.

Haninger-Vacariu N, El-Hadi S, Pauler U, Foretnik M, Kain R, Prohászka Z, Schmidt A, Skuban N, Barth JA, Sunder-Plassmann G.

Case Rep Obstet Gynecol. 2019 Dec 21;2019:1030259. doi: 10.1155/2019/1030259. eCollection 2019.

4.

Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients.

Aigner C, Böhmig GA, Eskandary F, Herkner H, Prohászka Z, Csuka D, Kain R, Gaggl M, Sunder-Plassmann R, Müller-Sacherer T, Oszwald A, Fischer G, Schmidt A, Sunder-Plassmann G.

Eur J Intern Med. 2020 Mar;73:51-58. doi: 10.1016/j.ejim.2019.11.007. Epub 2019 Nov 30.

PMID:
31791575
5.

C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathy.

Garam N, Prohászka Z, Szilágyi Á, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik-Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Romana Rysava, Reiterova J, Saraga M, Tomáš Seeman, Zieg J, Sládková E, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Csuka D.

Orphanet J Rare Dis. 2019 Nov 8;14(1):247. doi: 10.1186/s13023-019-1237-8.

6.

Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.

Winnicki W, Sunder-Plassmann G, Sengölge G, Handisurya A, Herkner H, Kornauth C, Bielesz B, Wagner L, Kikić Ž, Pajenda S, Reiter T, Schairer B, Schmidt A.

Sci Rep. 2019 Sep 24;9(1):13783. doi: 10.1038/s41598-019-50405-8.

7.

First case of late onset cardiac phenotype Fabry disease due to an AluYb8 insertion in exon 7 of the GLA gene.

Gatterer C, Beitzke D, Sunder-Plassmann R, Sunder-Plassmann G, Graf S.

Eur Heart J Cardiovasc Imaging. 2019 Oct 1;20(10):1182. doi: 10.1093/ehjci/jez083. No abstract available.

PMID:
31329829
8.

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

Riegersperger M, Plischke M, Jallitsch-Halper A, Steinhauser C, Födinger M, Winkelmayer WC, Dunkler D, Sunder-Plassmann G.

PLoS One. 2019 Jul 2;14(7):e0218709. doi: 10.1371/journal.pone.0218709. eCollection 2019.

9.

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy.

Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G.

Clin Kidney J. 2019 Apr 21;12(3):333-337. doi: 10.1093/ckj/sfz040. eCollection 2019 Jun.

10.

Oral Sodium Bicarbonate Supplementation Does Not Affect Serum Calcification Propensity in Patients with Chronic Kidney Disease and Chronic Metabolic Acidosis.

Aigner C, Cejka D, Sliber C, Fraunschiel M, Sunder-Plassmann G, Gaggl M.

Kidney Blood Press Res. 2019;44(2):188-199. doi: 10.1159/000498975. Epub 2019 May 8.

11.

Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study.

Hughes DA, Nicholls K, Sunder-Plassmann G, Jovanovic A, Feldt-Rasmussen U, Schiffmann R, Giugliani R, Jain V, Viereck C, Castelli JP, Skuban N, Barth JA, Bichet DG.

Am J Med Genet A. 2019 Jun;179(6):1069-1073. doi: 10.1002/ajmg.a.61105. Epub 2019 Mar 28. No abstract available.

12.

Kidney Injury by Variants in the COL4A5 Gene Aggravated by Polymorphisms in Slit Diaphragm Genes Causes Focal Segmental Glomerulosclerosis.

Frese J, Kettwig M, Zappel H, Hofer J, Gröne HJ, Nagel M, Sunder-Plassmann G, Kain R, Neuweiler J, Gross O.

Int J Mol Sci. 2019 Jan 26;20(3). pii: E519. doi: 10.3390/ijms20030519.

13.

Magnetic resonance imaging T1- and T2-mapping to assess renal structure and function: a systematic review and statement paper.

Wolf M, de Boer A, Sharma K, Boor P, Leiner T, Sunder-Plassmann G, Moser E, Caroli A, Jerome NP.

Nephrol Dial Transplant. 2018 Sep 1;33(suppl_2):ii41-ii50. doi: 10.1093/ndt/gfy198.

14.

Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.

Gaggl M, Aigner C, Csuka D, Szilágyi Á, Prohászka Z, Kain R, Haninger N, Knechtelsdorfer M, Sunder-Plassmann R, Sunder-Plassmann G, Schmidt A.

J Am Soc Nephrol. 2018 Mar;29(3):1020-1029. doi: 10.1681/ASN.2016090995. Epub 2017 Dec 27.

15.

Manifestations of neurological symptoms and thromboembolism in adults with MTHFR-deficiency.

Rommer PS, Zschocke J, Fowler B, Födinger M, Konstantopoulou V, Möslinger D, Stögmann E, Suess E, Baumgartner M, Auff E, Sunder-Plassmann G.

J Neurol Sci. 2017 Dec 15;383:123-127. doi: 10.1016/j.jns.2017.10.035. Epub 2017 Nov 6.

PMID:
29246599
16.

Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.

Winnicki W, Herkner H, Lorenz M, Handisurya A, Kikić Ž, Bielesz B, Schairer B, Reiter T, Eskandary F, Sunder-Plassmann G, Sengoelge G.

Kidney Int. 2018 Mar;93(3):753-760. doi: 10.1016/j.kint.2017.06.026. Epub 2017 Sep 8.

PMID:
28890326
17.

Blood volume-monitored regulation of ultrafiltration to decrease the dry weight in fluid-overloaded hemodialysis patients: a randomized controlled trial.

Antlanger M, Josten P, Kammer M, Exner I, Lorenz-Turnheim K, Eigner M, Paul G, Klauser-Braun R, Sunder-Plassmann G, Säemann MD, Hecking M.

BMC Nephrol. 2017 Jul 17;18(1):238. doi: 10.1186/s12882-017-0639-x.

18.

The Effect of ABCB1 Polymorphisms on Serial Tacrolimus Concentrations in Stable Austrian Long-Term Kidney Transplant Recipients.

Riegersperger M, Plischke M, Steinhauser C, Jallitsch-Halper A, Sengoelge G, Winkelmayer WC, Sunder-Plassmann G, Födinger M.

Clin Lab. 2016 Oct 1;62(10):1965-1972. doi: 10.7754/Clin.Lab.2016.160221.

PMID:
28164520
19.

Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study.

Hughes DA, Nicholls K, Shankar SP, Sunder-Plassmann G, Koeller D, Nedd K, Vockley G, Hamazaki T, Lachmann R, Ohashi T, Olivotto I, Sakai N, Deegan P, Dimmock D, Eyskens F, Germain DP, Goker-Alpan O, Hachulla E, Jovanovic A, Lourenco CM, Narita I, Thomas M, Wilcox WR, Bichet DG, Schiffmann R, Ludington E, Viereck C, Kirk J, Yu J, Johnson F, Boudes P, Benjamin ER, Lockhart DJ, Barlow C, Skuban N, Castelli JP, Barth J, Feldt-Rasmussen U.

J Med Genet. 2017 Apr;54(4):288-296. doi: 10.1136/jmedgenet-2016-104178. Epub 2016 Nov 10. Erratum in: J Med Genet. 2018 Apr 16;:.

20.

Fabry disease: A pharmacological chaperone on the horizon.

Gaggl M, Sunder-Plassmann G.

Nat Rev Nephrol. 2016 Nov;12(11):653-654. doi: 10.1038/nrneph.2016.138. Epub 2016 Sep 26. No abstract available.

PMID:
27665929

Supplemental Content

Loading ...
Support Center